Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | -6,46k | 1,35M | Automatic Disposition | 209,17 | 86,43k | -6,95% |
| 2026-06-15 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | -8,95k | 1,86M | Vendita | 207,84 | 86,43k | -9,38% |
| 2026-06-15 | Mr. Javier J. RodriguezCEO & Executive Director | -69,41k | 14,53M | Vendita | 209,28 - 209,50 | 775,74k | -8,21% |
| 2026-05-26 | Ms. Phyllis R. YaleIndependent Director | -5,04k | 0,00 | Other Disposition | - | 9,53k | -34,59% |
| 2026-05-14 | Mr. James O. HeartyCCO | -5,78k | 500,01k | Derivative Exercise and Sale | 110,63 - 198,10 | 13,91k | - |
| 2026-05-15 | Mr. James O. HeartyCCO | -13,56k | 2,63M | Vendita | 193,98 | 13,91k | -49,38% |
| 2026-05-11 | Mr. David P. MaughanCOO of DaVita Kidney Care | -20,53k | 4,09M | Vendita | 199,15 - 199,25 | 26,72k | -43,45% |
| 2026-05-07 | Mr. Joel AckermanCFO & Treasurer | -51,47k | 9,89M | Vendita | 192,10 | 97,92k | -34,45% |
| 2026-05-06 | Mr. James O. HeartyCCO | -2,18k | 381,92k | Vendita | 174,87 | 27,47k | -7,36% |
| 2026-05-01 | Berkshire Hathaway Inc.Società | -1,22M | 182,86M | Vendita | 149,84 | 28,88M | -4,05% |
| 2026-03-15 | Mr. David P. MaughanCOO of DaVita Kidney Care | -13,11k | 1,98M | Sale to Issuer | 150,72 | 47,08k | -21,78% |
| 2026-03-15 | Mr. James O. HeartyCCO | -11,58k | 1,75M | Sale to Issuer | 150,72 | 29,65k | -28,08% |
| 2026-03-15 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | -33,86k | 5,10M | Sale to Issuer | 150,72 | 101,84k | -24,95% |
| 2026-03-15 | Mr. Joel AckermanCFO & Treasurer | -42,82k | 6,45M | Sale to Issuer | 150,72 | 149,39k | -22,28% |
| 2026-02-06 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | 1,36k | 148,58k | Derivative Exercise and Retained Stock | 108,93 | 68,35k | 2,04% |
| 2026-02-06 | Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer | -6,72k | 270,55k | Derivative Exercise and Sale | 108,93 - 149,22 | 68,35k | - |
| 2026-02-06 | Mr. Joel AckermanCFO & Treasurer | 6,80k | 740,40k | Derivative Exercise and Retained Stock | 108,93 | 107,79k | 6,73% |
| 2026-02-06 | Mr. Joel AckermanCFO & Treasurer | -37,27k | 1,50M | Derivative Exercise and Sale | 108,93 - 149,22 | 107,79k | - |
| 2026-01-29 | Berkshire Hathaway Inc.Società | -1,66M | 199,94M | Vendita | 120,56 | 30,10M | -5,22% |
| 2025-12-04 | Mr. James O. HeartyCCO | 260,00 | 28,32k | Derivative Exercise and Retained Stock | 108,93 | 15,26k | 1,73% |
| 2025-12-04 | Mr. James O. HeartyCCO | -5,62k | 52,33k | Derivative Exercise and Sale | 108,93 - 118,25 | 15,26k | - |
| 2025-11-15 | Mr. Javier J. RodriguezCEO & Executive Director | -5,17k | 627,81k | Sale to Issuer | 121,55 | 845,14k | -0,61% |
| 2025-10-27 | Berkshire Hathaway Inc.Società | -401,51k | 54,35M | Vendita | 135,36 | 31,76M | -1,25% |
| 2025-09-22 | Mr. David P. MaughanCOO of DaVita Kidney Care | -7,50k | 976,33k | Sale to Issuer | 130,16 | 30,23k | -19,88% |
| 2025-07-31 | Berkshire Hathaway Inc.Società | -1,64M | 230,02M | Vendita | 140,61 | 32,16M | -4,84% |
| 2025-07-23 | Mr. James O. HeartyCCO | -2,35k | 352,65k | Automatic Disposition | 150,00 | 15,00k | -13,55% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
